EDITOR: Sen. Daniel Patrick Moynihan is often credited with saying, “Everyone is entitled to their own opinion, but they are ...
The move halts a large slice of money for most universities and research institutions virtually overnight, imperiling vital research in everything from cancer to heart disease.
The drastic reduction in indirect costs is not a path to innovation or cost savings — it’s a threat to U.S.’s position as global leader in medical research.